Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Nephrolithiasis
ADR ID BADD_A03021
ADR Hierarchy
20      Renal and urinary disorders
20.04      Urolithiases
20.04.01      Renal lithiasis
20.04.01.002      Nephrolithiasis
Description Formation of stones in the KIDNEY. [MeSH]
MedDRA Code 10029148
MeSH ID D053040; D007669
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Calculus kidney | Calculus of kidney | Calculus of kidney and ureter | Calculus renal | Calculus renal NOS | Crystallization kidney | Kidney calculus | Kidney crystallisation | Kidney stone | Kidney stones | Nephrolithiasis | Renal calculi | Renal calculus | Renal calculus NOS | Renal stone | Uric acid nephrolithiasis | Unilateral renal calculus | Kidney crystallization | Crystallisation kidney | Renal pelvic calcification | Nephrolithiasis recurrent | Gouty diathesis | Ureteropelvic junction stone | Renal microlithiasis | Bilateral nephrolithiasis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01209Isosorbide--
BADD_D01211Isosorbide mononitrate--
BADD_D01213Isotretinoin0.008336%
BADD_D01220Ivacaftor-
BADD_D01222Ixabepilone--
BADD_D01232Ketorolac--
BADD_D01242Lamivudine0.001518%
BADD_D01245Lansoprazole0.000298%
BADD_D01252Leflunomide0.000857%
BADD_D01253Lenalidomide0.026112%
BADD_D01256Lesinurad--
BADD_D01260Leuprolide acetate0.004302%
BADD_D01274Levodopa-4'-monophosphate--
BADD_D01275Levofloxacin--
BADD_D01285Levothyroxine0.000026%
BADD_D01292Linagliptin0.000243%
BADD_D01303Lithium carbonate0.000535%
BADD_D01309Lomefloxacin--
BADD_D01318Lorazepam--
BADD_D01336Macitentan0.001781%
BADD_D01359Mechlorethamine0.000112%
BADD_D01366Medroxyprogesterone acetate--
BADD_D01378Memantine--
BADD_D01392Mercaptopurine--
BADD_D01397Mesalamine0.000823%
BADD_D01401Metformin--
BADD_D01410Methazolamide--
BADD_D01418Methotrexate--
BADD_D01433Methylprednisolone--
BADD_D01470Minocycline--
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 10 Pages